# Pharmacokinetic Study of MIN-101 in Healthy Subjects

> **NCT02232529** · PHASE1 · COMPLETED · sponsor: **Minerva Neurosciences** · enrollment: 32 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** MIN-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02232529
- **Lead sponsor:** Minerva Neurosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2015-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02232529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02232529, "Pharmacokinetic Study of MIN-101 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02232529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*